NUTX vs. ATYR
NUTX (Nutex Health Inc) and ATYR (aTyr Pharma, Inc.) are both stocks. Both are in the Healthcare sector — NUTX in Health Information Services, ATYR in Biotechnology. Over the past 3 years, NUTX returned 30.28%/yr vs -40.12%/yr for ATYR. At a 0.15 correlation, their price movements are largely independent.
Performance
NUTX vs. ATYR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NUTX achieves a -8.78% return, which is significantly higher than ATYR's -39.96% return.
NUTX
- 1D
- -0.23%
- 1M
- 26.29%
- YTD
- -8.78%
- 6M
- -16.36%
- 1Y
- 31.86%
- 3Y*
- 30.28%
- 5Y*
- —
- 10Y*
- —
ATYR
- 1D
- 4.37%
- 1M
- -4.04%
- YTD
- -39.96%
- 6M
- -35.23%
- 1Y
- -90.99%
- 3Y*
- -40.12%
- 5Y*
- -36.40%
- 10Y*
- -35.88%
NUTX vs. ATYR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NUTX Nutex Health Inc | -8.78% | 419.47% | 17.37% | -90.53% | -81.82% |
ATYR aTyr Pharma, Inc. | -39.96% | -78.37% | 156.74% | -35.62% | -60.82% |
Correlation
The correlation between NUTX and ATYR is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Apr 4, 2022 | 0.15 |
The correlation between NUTX and ATYR shifts across timeframes, from 0.04 (1 year) to 0.15 (all time), reflecting how their relationship changes across market environments.
Fundamentals
NUTX:
$19.08
ATYR:
-$0.73
NUTX:
0.86
ATYR:
237.16
NUTX:
$879.95M
ATYR:
$190.00K
NUTX:
$417.67M
ATYR:
-$22.33M
NUTX:
$275.94M
ATYR:
-$71.35M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NUTX vs. ATYR — Risk / Return Rank
NUTX
ATYR
NUTX vs. ATYR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutex Health Inc (NUTX) and aTyr Pharma, Inc. (ATYR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NUTX | ATYR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.00 | ||
| Sortino ratioReturn per unit of downside risk | +1.86 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 0.87 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 0.59 | -0.97 | +1.56 |
| Martin ratioReturn relative to average drawdown | 1.03 | -1.17 | +2.20 |
Loading charts...
Drawdowns
NUTX vs. ATYR - Drawdown Comparison
The maximum NUTX drawdown since its inception was -99.93%, roughly equal to the maximum ATYR drawdown of -99.90%. Use the drawdown chart below to compare losses from any high point for NUTX and ATYR.
Loading charts...
Drawdown Indicators
| NUTX | ATYR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.93% | -99.90% | -0.03% |
Max Drawdown (1Y)Largest decline over 1 year | -54.32% | -94.01% | +39.69% |
Max Drawdown (3Y)Largest decline over 3 years | -93.95% | -94.01% | +0.06% |
Max Drawdown (5Y)Largest decline over 5 years | — | -96.83% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.55% | — |
Current DrawdownCurrent decline from peak | -97.50% | -99.88% | +2.38% |
Average DrawdownAverage peak-to-trough decline | -97.18% | -93.17% | -4.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.02% | 77.49% | -46.47% |
Volatility
NUTX vs. ATYR - Volatility Comparison
The current volatility for Nutex Health Inc (NUTX) is 16.28%, while aTyr Pharma, Inc. (ATYR) has a volatility of 21.70%. This indicates that NUTX experiences smaller price fluctuations and is considered to be less risky than ATYR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NUTX | ATYR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.28% | 21.70% | -5.42% |
Volatility (6M)Calculated over the trailing 6-month period | 62.51% | 95.12% | -32.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.38% | 139.96% | -46.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 191.46% | 89.87% | +101.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 191.46% | 88.44% | +103.02% |
Dividends
NUTX vs. ATYR - Dividend Comparison
Neither NUTX nor ATYR has paid dividends to shareholders.
Financials
NUTX vs. ATYR - Financials Comparison
This section allows you to compare key financial metrics between Nutex Health Inc and aTyr Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NUTX and ATYR have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATYR has higher volatility (21.70%) compared to NUTX (16.28%). In terms of maximum drawdown, NUTX dropped -99.93% vs ATYR's -99.90%.
NUTX currently has the higher Sharpe Ratio (0.34 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NUTX and ATYR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer